Zykadia and Inflammation - a phase IV clinical study of FDA data

Summary:

Inflammation is reported as a side effect among people who take Zykadia (ceritinib), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Morphine, and have C-reactive protein increased.

The phase IV clinical study analyzes which people have Inflammation when taking Zykadia. It is created by eHealthMe based on reports of 2,091 people who have side effects when taking Zykadia from the FDA, and is updated regularly.

What is Zykadia?

Zykadia has active ingredients of ceritinib. eHealthMe is studying from 2,091 Zykadia users. Check the latest studies of Zykadia.

What is Inflammation?

Inflammation is found to be associated with 1,706 drugs and 1,873 conditions by eHealthMe. Check the latest studies of Inflammation.

On Jun, 18, 2026

2,091 people reported to have side effects when taking Zykadia.
Among them, 10 people (0.48%) have Inflammation.

Among these 10 people:

How long have people been on Zykadia when they have Inflammation? *

What is the gender of people who have Inflammation when taking Zykadia? *

female: 80 %
male: 20 %

What is the age of people who have Inflammation when taking Zykadia? *

What are other drugs people take besides Zykadia? *

Morphine: 1 person, 10.00%

What are other side effects people have besides Inflammation? *

Fever: 7 people, 70.00%
White Blood Cell Count Increased: 5 people, 50.00%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 5 people, 50.00%
C-Reactive Protein Increased: 5 people, 50.00%
Biliary Tract Disorder: 4 people, 40.00%
Blood Bilirubin Increased: 4 people, 40.00%
Cholangitis (infection of the bile duct): 4 people, 40.00%
Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 4 people, 40.00%
Dilatation Intrahepatic Duct Acquired: 4 people, 40.00%
Headache (pain in head): 4 people, 40.00%

What are the existing conditions these people have? *

White Blood Cell Count Increased: 4 people, 40.00%
Non-Small Cell Lung Cancer Stage Iv: 4 people, 40.00%
Lung Cancer - Non-Small Cell (lung cancer): 4 people, 40.00%
Fever: 4 people, 40.00%
Escherichia Urinary Tract Infection (urinary tract infection by escherichia coli): 4 people, 40.00%
C-Reactive Protein Increased: 4 people, 40.00%
Lung Adenocarcinoma (a form of non-small cell lung cancer): 2 people, 20.00%
Pain: 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Zykadia and have Inflammation?

- Check whether Inflammation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zykadia:

Zykadia (2,091 reports)

Inflammation treatments and more:

Inflammation (78,905 reports)

Browse all side effects of Zykadia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Inflammation:

Inflammation (1,706 drugs)

Browse all the conditions that are associated with Inflammation:

Inflammation (1,873 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ceritinib (the active ingredients of Zykadia) and Zykadia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.